-
Product Insights
Avian Influenza Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Avian Influenza Global Clinical Trials Review, H2, 2017" provides an overview of Avian Influenza clinical trials scenario. This report provides top line data relating to the clinical trials on Avian Influenza. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Haemophilus influenzae Infections Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Haemophilus influenzae Infections Global Clinical Trials Review, H2, 2017" provides an overview of Haemophilus influenzae Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Haemophilus influenzae Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Haemophilus influenzae Type B Infections Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Haemophilus influenzae Type B Infections Global Clinical Trials Review, H2, 2017" provides an overview of Haemophilus influenzae Type B Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Haemophilus influenzae Type B Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Hand, Foot and Mouth Disease Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Hand, Foot and Mouth Disease Global Clinical Trials Review, H2, 2017" provides an overview of Hand, Foot and Mouth Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Hand, Foot and Mouth Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2017" provides an overview of Cytomegalovirus (CMV) Retinitis clinical trials scenario. This report provides top line data relating to the clinical trials on Cytomegalovirus (CMV) Retinitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Sector Analysis
Hepatitis B - Competitive Landscape to 2027
Hepatitis B is a viral infection of the liver that can become chronic in young children, especially newborns to mothers with HBV infections, and people with compromised immune systems. Chronic hepatitis B is defined as measurable hepatitis B surface antigen (HBsAg) levels for more than six months after an acute infection. Despite the existence of prophylactic vaccines, hepatitis B remains a global public health threat, with approximately 257 million people worldwide living with chronic HBV infections. Chronic hepatitis B cannot...
-
Sector Analysis
Pediatric Vaccines - Epidemiology Forecast to 2028
The administration of a vaccine, referred to as vaccination, elicits an immune response that prevents an individual from developing a specific disease when exposed to the corresponding infectious agent in the future. A successful vaccination results in immunization, where the individual is deemed immune to the disease. Routine immunization programs aim to protect children at an early age, when they are the most vulnerable to disease. Prior to the discovery of vaccines, several infectious diseases claimed the lives of millions...
-
Product Insights
Dermatomycoses Disease - Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Dermatomycoses Global Clinical Trials Review, H1, 2019" provides an overview of Dermatomycoses clinical trials scenario. This report provides top line data relating to the clinical trials on Dermatomycoses. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Dermatophytosis Disease - Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Dermatophytosis Global Clinical Trials Review, H1, 2019" provides an overview of Dermatophytosis clinical trials scenario. This report provides top line data relating to the clinical trials on Dermatophytosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Diphtheria Disease - Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Diphtheria Global Clinical Trials Review, H1, 2019" provides an overview of Diphtheria clinical trials scenario. This report provides top line data relating to the clinical trials on Diphtheria. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.